GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Pretax Margin %

VACBF (Nykode Therapeutics AS) Pretax Margin % : -2,348.88% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Nykode Therapeutics AS's Pre-Tax Income for the three months ended in Sep. 2024 was $-12.59 Mil. Nykode Therapeutics AS's Revenue for the three months ended in Sep. 2024 was $0.54 Mil. Therefore, Nykode Therapeutics AS's pretax margin for the quarter that ended in Sep. 2024 was -2,348.88%.

The historical rank and industry rank for Nykode Therapeutics AS's Pretax Margin % or its related term are showing as below:

VACBF' s Pretax Margin % Range Over the Past 10 Years
Min: -48962.79   Med: -526.48   Max: 84.14
Current: -1225.55


VACBF's Pretax Margin % is ranked worse than
75.91% of 1013 companies
in the Biotechnology industry
Industry Median: -148.6 vs VACBF: -1225.55

Nykode Therapeutics AS Pretax Margin % Historical Data

The historical data trend for Nykode Therapeutics AS's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Pretax Margin % Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial - 84.14 -32.74 -711.26 -341.70

Nykode Therapeutics AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -449.75 -469.10 -1,988.88 -1,743.93 -2,348.88

Competitive Comparison of Nykode Therapeutics AS's Pretax Margin %

For the Biotechnology subindustry, Nykode Therapeutics AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nykode Therapeutics AS's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nykode Therapeutics AS's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Nykode Therapeutics AS's Pretax Margin % falls into.



Nykode Therapeutics AS Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Nykode Therapeutics AS's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-44.086/12.902
=-341.70 %

Nykode Therapeutics AS's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-12.59/0.536
=-2,348.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nykode Therapeutics AS  (OTCPK:VACBF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Nykode Therapeutics AS Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nykode Therapeutics AS Business Description

Traded in Other Exchanges
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.